Dalix Therapeutics Inc — Form D

Dalix Therapeutics Inc of VALLEY STREAM, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-11. The offering totals $6.0M, of which $750K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-02-11
• Form: D
• Accession: 0001615774-16-004151
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $6.0M
• Amount sold: $750K
• Remaining: $5.3M
• Investors: 3
• Date of first sale: 2016-01-26
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-257250

Issuer

• Name: Dalix Therapeutics Inc
• CIK: 0001666562
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: C/O DAVID LUBIN & ASSOCIATES, VALLEY STREAM, NY, 11580
• Phone: 516-887-8200

Officers, directors & promoters (7)

More

• CIK 1666562 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search